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Abstract
Mutations in superoxide dismutase (SOD1) are causative for inherited amyotrophic lateral sclerosis. A proportion of SOD1
mutant protein is misfolded onto the cytoplasmic face of mitochondria in one ormore spinal cord cell types. By construction of
mice in which mitochondrially targeted enhanced green fluorescent protein is selectively expressed in motor neurons, we
demonstrate that axonal mitochondria of motor neurons are primary in vivo targets for misfolded SOD1. Mutant SOD1 alters
axonal mitochondrial morphology and distribution, with dismutase active SOD1 causing mitochondrial clustering at the
proximal side of Schmidt-Lanterman incisures within motor axons and dismutase inactive SOD1 producing aberrantly
elongated axonal mitochondria beginning pre-symptomatically and increasing in severity as disease progresses. Somal
mitochondria are altered by mutant SOD1, with loss of the characteristic cylindrical, networked morphology and its
replacement by a less elongated, more spherical shape. These data indicate that mutant SOD1 binding to mitochondria
disrupts normal mitochondrial distribution and size homeostasis as early pathogenic features of SOD1 mutant-mediated ALS.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a prominent adult-onset
motor neuron disease characterized by the progressive and
selective loss of motor neurons of the motor cortex, brainstem
and spinal cord [1]. While the cause of the majority of cases
remains unknown, ,10% of instances are genetically inherited,
with the most frequent cause being mutations in the ubiquitously
expressed Cu,Zn superoxide dismutase 1 (SOD1). The nature of
SOD1 mutant toxicity and its selectivity for motor neurons
remains unsettled. Seven highly divergent cellular mechanisms for
mutant SOD1-mediated damage have been proposed [2],
including inhibition of the voltage dependent ion channel
(VDAC1) [3] and protein import through the TOM complex
[4] following binding of misfolded mutant SOD1 onto the
cytoplasmic face of spinal cord mitochondria [5]. These latter
interactions are unique to spinal mitochondrial membranes, but
the cell type(s) in which this interaction(s) occurs is not established.
Disturbed mitochondrial ultrastructure in motor neurons and
muscles in both sporadic and familial ALS first implicated
mitochondria in ALS pathogenesis [6–9]. Similar alterations of
mitochondria, including vacuolated, dilated and disorganized
mitochondria were later identified in spinal motor neuron cell bodies
of mutant SOD1 mouse models expressing dismutase active [10–13],
but not inactive mutants [14]. The frequency of these abnormalities
and their neuronal distribution, especially within axons, has not been
determined. Through generation of a transgenic mouse line with
mitochondrially targeted EGFP expressed only in motor neurons, we
now identify abnormally swollen mitochondria within motor neuron
cell bodies, reduced number of axonal mitochondria, and a highly
surprising misdistribution along axons as common features of early
pathogenesis in SOD1-mediated inherited ALS.
Results
A transgenic mouse line with selective fluorescent
labeling of motor neuron mitochondria
To assess the relative distributions and morphologies of
mitochondria uniquely within motor neurons, four transgenic
mouse lines were generated in which EGFP was selectively
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synthesized by motor neurons and directed into mitochondria
(Fig. 1A, B) by in frame ligation to the 25 amino acid targeting
sequence from the mitochondrial matrix component Cytochrome
c oxidase subunit VIII. This fusion gene was placed under the
transcriptional control of the mouse Hb9 promoter, whose
expression is unique to the motor neuron lineage [15,16] and
whose expression persists in 10–20% of adult motor neurons [17].
Immunofluorescence of spinal cord sections was used to determine
Figure 1. Generation of a novel transgenic mouse with mitochondria labeled uniquely in motor neurons. (A) Schematic of Hb9-
MitoEGFP transgene. (B) Immunoblot of spinal cord homogenates of Hb9-MitoEGFP founders (F34, F17, F36, F20) and F34 sublines probed for EGFP
and tubulin (loading control). (C–G) MitoEGFP (green) expression in spinal cord motor neurons (C & D), sciatic nerve (E), and L5 motor axons (F & G)
labeled with SMI32 (C, red), cytochrome c (D & F, red), and Fluoromyelin Red (F & G, blue/red). Note that mitochondria have typical tubular and
punctate morphologies and MitoEGFP expression is excluded from Schwann cells. (G & H) 15% of large caliber (.4.5 mm) L5 motor axons express
MitoEGFP in 12 months animal. The expected biphasic distribution of axonal caliber in adult C57Bl/6 mice is indicated in the upper right corner.
Comparison of axonal and somal mitochondrial length (I), width (J) and aspect ratio (K) in Hb9-MitoEGFP mice. Scale bars, 10 mm.
doi:10.1371/journal.pone.0022031.g001
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that varying levels and patterns of MitoEGFP were present in the
different lines, with the highest level and motor neuron-restricted
expression found in subline 34–116. This line, referred to hereafter
as Hb9-MitoEGFP, was maintained hemizygous and backcrossed
three generations into C57Bl/6 to generate mice enriched in this
background.
Hb9-MitoEGFP mice were phenotypically normal with typical
gait, posture, and hind-limb reflexes. Consistent with the expected
mitochondrial pattern, EGFP accumulated in a speckled pattern
within motor neurons of the ventral spinal cord and was comprised
of a mix of both tubular and punctate morphologies (Fig. 1C, D).
Higher magnification images confirmed co-localization of Mi-
toEGFP with the mitochondrial marker cytochrome c in nearly all
mitochondria accumulating MitoEGFP (Fig. 1D). Occasional
mitochondrial labeling was also observed in a few small neurons
near the central spinal canal. These cells are likely to be
interneurons and were excluded from subsequent analyses.
Mitochondria were detected in long linear tracts in axons within
the sciatic nerves of Hb9-MitoEGFP mice (Fig. 1E, F). Within
ventral roots, MitoEGFP was restricted to axonal mitochondria and
excluded from myelinating Schwann cells (Fig. 1F). Fifteen percent
of L5 ventral axons contained Hb9 driven MitoEGFP (Fig. 1G), all
of which were the large-caliber (.4.5 mm; Fig. 1H) axons at-risk in
ALS [18] and SOD1 mutant mediated ALS-like disease in mice
[14]. Morphology of EGFP-marked mitochondria was indistin-
guishable from those in non-EGFP expressing neurons (Fig. 1D).
Axonal and somal mitochondria are morphologically
distinct
In both normal mitochondria and those expressing EGFP the
morphology of mitochondria was different between the cell body and
axonal compartments with both found in an interconnected network
within motor neuron cell bodies, while axonal mitochondria were
present as distinct entities often with an elongated appearance
(compare Fig. 1D, F). Mitochondrial length, width, and aspect ratio
(the ratio of length to width) within motor axons and somata of Hb9-
MitoEGFP mice were determined (90% of individual morphologies
were scored with semi-automated custom software, with the
remaining 10% separated manually owing to more complex
connecting linkages). A greater proportion of axonal mitochondria
were longer than 0.5 mm compared with those in the soma
(32.161.5% vs. 23.863.5%, p,0.05) (Fig. 1I). Furthermore, by 8
months of age, average mitochondrial length was increased by,50%
in axons compared to cell bodies (0.9160.03 mm vs. 0.6460.01 mm,
p,2610240). While mitochondrial diameters (i.e., width in one-
dimension) have been reported in most cellular contexts as 200–
300 nm [19], the population of axonal mitochondria were of
significantly (p,0.03) smaller diameters (e.g., 48.961.9% of axonal
mitochondria had diameters less than 125 nm, compared to
33.764.8% in the soma) (Fig. 1J). Indeed, somal mitochondrial
diameters (widths) were 20% larger than axonal mitochondria
(0.3660.01 mm vs. 0.3060.01 mm, p,1610237). Aspect ratio
provided an unbiased measure of asymmetry in shape: the proportion
of punctal mitochondria (aspect ratio near 1) within axons was
markedly reduced compared to motor neuron cell bodies
(46.461.7% vs. 71.661.4%, p,0.00002) (Fig. 1K). We conclude
that there are significant compartmental differences in mitochondrial
morphology between cell bodies and axons of motor neurons.
Misfolded SOD1 associates with axonal mitochondria in
vivo
We exploited the Hb9-MitoEGFP mouse to visualize mito-
chondrial distribution and morphology in the context of mutant
SOD1-mediated ALS in previously characterized transgenic
mouse lines expressing either of two ALS-linked SOD1 mutants,
SOD1G37R (dismutase active) and SOD1G85R (dismutase inactive).
These two mutant SOD1 lines develop clinical disease features of
early paralysis and muscle wasting at 5 and 11 months,
respectively. Introduction of the Hb9-MitoEGFP transgene did
not significantly change the life span or phenotype of these
animals. Using a monoclonal antibody (DSE2) raised against the
carboxyl-terminal domain of SOD1 that is inaccessible in properly
folded SOD1, immunoprecipitation has previously been used to
demonstrate the preferential association of misfolded SOD1 with
the surface of spinal cord mitochondria [5] and that a portion of
this mitochondrially associated mutant SOD1 is bound directly to
VDAC1 [3].
To determine in which cell type(s) this misfolded mutant SOD1
accumulates, we took advantage of an additional monoclonal
antibody (mAb A5C3) that is suitable for immunofluorescence and
which uniquely recognizes a misfolded SOD1 epitope within exon
4 [20]. Examinations of spinal cord sections from early
symptomatic (10 month) SOD1G85R mice revealed an enrichment
of misfolded SOD1 within motor neuron axons as visualized in L5
ventral roots (Fig. 2A). Misfolded SOD1 was completely absent in
sensory axons of the dorsal root (Fig. 2B). Closer inspection of
ventral axons revealed frequent colocalization of misfolded SOD1
with motor axonal mitochondria, as labeled with MitoEGFP, in
both early symptomatic SOD1G85R (Fig. 2C, D) and SOD1G37R
mice (Fig. 2E, F). To determine the extent of colocalization, we
used non-biased imaging software to quantify the overlap
coefficient between individual mitochondria labeled with Mi-
toEGFP and mAb A5C3, where a value of one represents the
maximum degree of colocalization. By this approach, we
determined the average overlap coefficient between MitoEGFP
and mAb A5C3 as 0.91360.007 and 0.91560.009 for SOD1G85R
and SOD1G37R ventral axons, respectively. We also noted some
enrichment of misfolded SOD1 which partially corresponded with
mitochondrial labeling at sites consistent with axonal exit zones
(Fig. 2G). Misfolded SOD1 was not detectable in the ventral
axons of MitoEGFP mice under the same conditions, as expected
(Fig. 2H). These data establish that misfolded SOD1 primarily
accumulates on (and/or in) motor axon mitochondria in vivo.
Mutant SOD1 changes to somal and axonal mitochondria
in motor neurons
Age-dependent changes were seen in mitochondria of motor
neurons within SOD1 mutant mice. By 4.5 months, the initial
mitochondrial network within motor neuron perikarya of
SOD1G37R mice became less connected, with discrete, nearly
circular (with aspect ratio near 1) mitochondria appearing more
often (compare Fig. 3A–D). Many of these mitochondria had
strikingly large (diameters .1 mm) (Fig. 3B–D), with average
mitochondrial length and aspect ratio reduced 22% and 15%,
respectively (Fig. 3E, F; Fig. 4). Similar reductions were
identified in length (26%) and aspect ratio (10%) in 10 month
(but not 7 or 8 month) SOD1G85R animals. Rounding of motor
neuron mitochondria in both SOD1G85R and SOD1G37R mice
was achieved by a shortening of mitochondrial length (Fig. 4B),
rather than increased width (Fig. 4C).
In the absence of mutant SOD1, mitochondria (both tubular
and punctal) of Hb9-MitoEGFP mice were distributed homo-
genously along the length of each motor axon (Fig. 5A). In
contrast, in SOD1G85R (Fig. 5B–E) and SOD1G37R mice
(Fig. 5F, G) mitochondria became progressively smaller, rounder,
and unevenly distributed along axons. Strings of 3–4 mitochondria
abutting each other much like pearls on a string were frequently
Misfolded Mutant SOD1 Alters Mitochondria
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Figure 2. Misfolded SOD1 associates with motor neuron axonal mitochondria in vivo. An antibody raised against misfolded SOD1 (A5C3,
red) labels ventral (A) but not dorsal (B) axons of 10 month SOD1G85R mouse. Myelin Basic Protein (MBP, blue) is included as a counter-label. Misfolded
SOD1 (A5C3, red) is often colocalized with mitochondria (EGFP, green) in motor axons of both SOD1G85R (C & D) and SOD1G37R animals (E & F) but not
non-SOD1 MitoEGFP littermates (H). Regions of the spinal cord, consistent with axonal exit zones also demonstrate double-labeling (G). The
boundaries of individual axons are indicated either by MBP labeling (blue) or dotted lines. Scale bars are as indicated.
doi:10.1371/journal.pone.0022031.g002
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found in axons from both SOD1 mutants (Fig. 5E–G), consistent
with increased mitochondrial fission and/or decreased fusion.
Mitochondrial area (calculated based on the number of pixels
composing each separate object) within SOD1G37R and
SOD1G85R axons and (Fig. 5I) increased 45% and 27% in axons
of 6 and 10 month old SOD1G85R animals, respectively (6 months:
0.2960.02 vs. 0.2060.01 mm2, p,0.00003; 10 months:
0.2860.01 vs. 0.2260.01 mm2, p,0.02). Similarly, a trend almost
reaching statistical significance for increased (by 50%) mitochon-
drial area (p,0.08) was detected in early symptomatic SOD1G37R
axons (0.2760.06 vs. 0.1860.01 mm2).
In both mutant SOD1 lines, these increases reflect progressive
increases in the areas of the largest mitochondria (right-most bin),
at the expense of smaller mitochondria (Fig. 4E). Each
mitochondrion was fit to an elliptical shape so as to define length
and width for each mitochondrion (Fig. 5J). In SOD1G37R
animals, the observed changes in mitochondrial area were
accompanied by a statistically significant, 22% decrease in length
(Fig. 5K) and 48% increase in width (Fig. 4H), respectively. This
was reflected in a significant 41% reduction in aspect ratio,
indicating that SOD1G37R mitochondria are becoming less tubular
and increasingly round (1.5660.05 vs. 2.6460.10, p,4.2610219)
Figure 3. Motor neuron mitochondria are rounder in mutant SOD1 mice. MitoEGFP (green) expression in spinal cord motor neurons in
control MitoEGFP (A) and SOD1G37R early symptomatic animals (B–D). The control neuron has normal mitochondria of diverse shapes and sizes. In
contrast, SOD1G37R motor neurons have rounded swollen mitochondria with uneven distribution. Arrows indicate possible axon hillocks. Motor
neuron boundaries have been outlined with dotted line. Quantification of mitochondrial length (E) and aspect ratio (F) in motor neuron cell bodies of
mutant SOD1 animals of various ages and age-matched MitoEGFP control animals. ***, p,0.0005. Scale bars, 10 mm.
doi:10.1371/journal.pone.0022031.g003
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Figure 4. Distributions of mitochondrial morphology and distribution. Distributions in various morphological parameters of somal (A–D) and
axonal (E–H) mitochondria. Bins for area (A,E) are 0–0.25, 0.26–0.50, 0.51–0.75, 0.76–1.0, and .1.0 mm2. Bins for length (B,F) are 0–1, 1.01–2, 2.01–3,
3.01–4, and.4 mm. Bins for aspect ratio (C,G) are 1–2, 2.01–4, 4.01–6, 6.01–8, and.8. Bins for width (D,H) are 0–0.25, 0.26–0.50, 0.51–0.75, 0.76–1.0, and
.1.0 mm. Statistics have been calculated using Chi-square with Yates’ correction for continuity and significant differences in distributions are indicated:
*, p,0.05; **, p,0.005; ***, p,0.0005.
doi:10.1371/journal.pone.0022031.g004
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Figure 5. Mitochondria morphology is altered in mutant SOD1 axons. MitoEGFP (green) expressed in the sciatic nerves in control (A),
asymptomatic SOD1G85R 7 months (B and C), SOD1G85R 8 months (D and E), and SOD1G37R early symptomatic (F and G) labeled with Fluoromyelin red
(red). Round and evenly distributed mitochondria are seen in both SOD1G85R (symptomatic stage) and SOD1G37R (early symptomatic stage).
Misfolded Mutant SOD1 Alters Mitochondria
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compared to age-matched controls (Fig. 4G, Fig. 5K). In
SOD1G85R axons, at all time points examined, mitochondrial
lengths were observed to be increased relative to age-matched
controls (Fig. 4F, Fig. 5J), resulting in an average 17% increase in
aspect ratio (2.9760.04 vs. 2.5460.03, p,0.0008) (Fig. 5K).
Histograms confirmed that at very early, pre-symptomatic ages,
SOD1G85R axonal mitochondrial were longer (though not
necessarily narrower), and thus more tubular compared to non-
SOD1 transgenic controls (Fig. 4E–H).
Mutant SOD1 induces misdistribution of mitochondria in
motor axons
In the absence of mutant SOD1, axonal mitochondria
distributions were relatively homogeneous throughout the length
of the axons (Fig. 5A). Mitochondrial distribution in the motor
axons in sciatic nerves of Hb9-MitoEGFP mice expressing either
SOD1G37R or SOD1G85R mutations was markedly different. At
the earliest phenotypic stages, mitochondrial distributions were
obviously disrupted in SOD1G37R animals (Fig. 5F, G), including
reduced mitochondrial densities (measured as the number of
mitochondria per axonal segment) in early symptomatic
SOD1G37R and SOD1G85R animals. Mean residual regression
analysis of mitochondrial distribution as a function of the deviation
from a constant density confirmed increased variability in
mitochondrial axonal distribution of early symptomatic
SOD1G37R and pre-symptomatic 8 month SOD1G85R axons.
The magnitude of residual regression was increased nearly 2-fold
in SOD1G37R motor axons (0.07960.008 vs. 0.04060.010,
p,0.04) and 1.8-fold in 8 month SOD1G85R axons
(0.04660.007 vs. 0.02660.002, p,0.01) compared to respective
age-matched controls (Fig. 5L). (Small values for regression
residuals reflect a constant density along the axon, while larger
values reflect variable mitochondrial density.).
The most striking feature was preferential accumulation of
mitochondria within SOD1G37R axons (Fig. 5F, G) just proximal
to Schmidt-Lanterman incisures (SLI), readily identifiable struc-
tures in peripheral myelin where a small amount of Schwann cell
cytoplasm has been displaced. These sites correspond to areas of
increased neurofilament packing, thus restricting axonal diameter
[21,22]. The functions of SLIs are not established, but they are
believed to participate in axon-glial communication [21,22].
When the average mitochondrial density in all axonal regions
distal to the incisures was compared to the density for a 7.0 mm
region (two 3.5 mm segments/bins) proximal to each incisures,
there was a striking 6-fold decrease in mitochondrial density at the
distal side of incisures of SOD1G37R axons (1.960.5 vs. 0.360.1,
p,0.04). In contrast, no significant mitochondrial clustering at
SLIs was detected in SOD1G85R axons at any time point
examined.
Discussion
The maintenance of optimal mitochondrial function, transport
and distribution is essential to motor neuron survival [23]. Using a
new transgenic mouse model which permits the direct visualization
of axonal and somal mitochondria of motor neurons, we report
important differences in mitochondrial morphology in these two
compartments (Fig. 1). Where prior efforts had identified
preferential deposition of misfolded SOD1 onto some spinal cord
mitochondria [5,24], including portions directly complexed to
VDAC1 [3] or the anti-apoptotic BCL-2 [25], or impacting the
TOM mitochondrial protein import channel [4], we have now
established that a component of disease common to dismutase
active and inactive SOD1 mutants is misdistribution and altered
morphology of axonal mitochondria within motor neurons
accompanied by intra-axonal accumulation of misfolded SOD1.
Mitochondria within motor neuron cell bodies are also noticeably
swollen (shifting from tubular) and less interconnected morphol-
ogies (Fig. 2). Considering that axons account for 99% of the total
motor neuron volume, and the relative abundance of mitochon-
dria within these axons, the disturbances in axonal mitochondrial
geometry and distribution we describe here would be expected to
have a significant impact on the overall function of the motor
neuron.
Perhaps even more striking is that our evidence has revealed the
common finding that somal mitochondria become shorter and
rounder in both dismutase active and inactive mutant SOD1 lines
(Fig. 3). In the case of SOD1G37R, grossly enlarged mitochondria
with diameters exceeding 1 mm were found. However, in axons,
where well-organized and tightly packed cytoskeletal filaments
may impose additional geometric restrictions on mitochondrial
shape [26], we observed significant changes in mitochondrial
morphology in these mutant SOD1 lines with SOD1G37R
mitochondria shifting from long, tubular mitochondria to punctate
mitochondria, while SOD1G85R mitochondria underwent an
increase in length. These morphological changes are accompanied
by the development of a non-homogenous mitochondrial distri-
bution along the length of the axon, most striking of which are the
focal concentrations of mitochondria within SOD1G37R axons at
the proximal sides of SLIs (Fig. 5). Our findings are consistent
with mitochondrial morphology observed following acute injury
(e.g., intercostal nerve-muscle explants) where long, tubular,
extended mitochondrial forms shifted noticeably to smaller,
immobile ones [27]. While both mutant SOD1s clearly alter
axonal mitochondrial morphology and distribution, the final
mitochondrial shape and positioning differs in axons of animals
expressing each mutant. Since there are intrinsic differences in
dismutase activity between these two mutants, this may account
for the differences in mitochondrial morphology and distribution
triggered by each mutant.
The morphological changes to mitochondria are accompanied
by the development of a non-homogenous mitochondrial distri-
bution along the length of motor axons, most striking of which are
the focal concentrations of mitochondria within SOD1G37R axons
at the proximal sides of SLIs. From this, we propose that the
clusters of mitochondria containing mutant SOD1 observed at
regular intervals in axoplasm from teased nerve whole mounts
prepared from pre-symptomatic rats expressing dismutase active
SOD1G93A [28] represent similar mitochondrial pileups at the
proximal sides of SLIs.
The marked change in mitochondrial geometry is likely of
functional significance since it has previously been demonstrated
in cultured cerebellar granule neurons that agents which induce
mitochondrial swelling without affecting ATP production cause a
severe impairment in mitochondrial motility [19]. Thus, major
alterations in mitochondrial geometry can impair trafficking,
Mitochondria`pile-ups` or clusters are also seen in the proximal side of SLIs (arrows) in the SOD1G37R axons. Arrowheads indicate ‘‘strings’’ of
mitochondria. Arrows indicate SLIs (H) Schematic indicating proximal and distal locations of SLIs. Mitochondrial area (I), length (J), aspect ratio (K), and
density (L) were evaluated in motor axons of the sciatic nerves of and mutant SOD1 animals of various ages and age-matched MitoEGFP control
animals, as described in detail in the Materials and Methods. Statistics are indicated: *, p,0.05; **, p,0.005; ***, p,0.0005.
doi:10.1371/journal.pone.0022031.g005
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without affecting energy production. Similarly, altered mitochon-
drial morphology is observed following acute injury (e.g., in
intercostal nerve-muscle explants where long, tubular, extended
mitochondrial forms shifted to smaller, immobile grains [27]. That
mitochondrial swelling may be a key component in ALS is further
supported by a recent claim that deletion of Cyclophilin D, a
regulator of the mitochondrial permeability transition pore, itself a
regulator of mitochondrial volume, successfully reduced mito-
chondrial swelling and delayed disease in SOD1G93A mice [29]
(note, however, that our own unpublished efforts with a similar
genetic approach do not confirm the reported benefit; S. Da Cruz,
P. Parone, and D.W.C). Further, deletion or overexpression of
VDAC1 in Drosophila indirect flight muscles results in elongated
and fragmented mitochondria, respectively [30].
The pileup of mitochondria in dismutase active SOD1 mutants
that we have documented at the proximal sides of the SLIs mirrors
mitochondrial changes in morphology and depletion from axons
following axotomy, in the latter case through a combination of
decreased anterograde motor activity for mitochondria without a
change in stationary phases or alteration in retrograde mitochon-
drial movement [31]. Indeed, enhanced retrograde movement of
mitochondria, and consequent depletion of mitochondria at distal
terminals in SOD1G93A embryonic motor neurons or transfected
cortical neurons has been linked to perturbation of the
anterograde component of fast axonal transport and mutant
SOD1 has been shown to slow anterograde transport within
axoplasm in vitro [31,32]. In light of this and our findings here
using a novel transgenic mouse line to report uniquely on motor
neuron mitochondrial distribution and geometry, we now propose
that misfolded SOD1 within motor neurons inhibits mitochondrial
ability to regulate their volume (and morphology), which in turn
negatively impacts their axonal positioning, at least in part by
affecting anterograde axonal transport within motor axons as an
early, and possibly central aspect of disease pathogenesis. In
addition, the development of this novel transgenic line Hb9-
MitoEGFP has revealed an important impact of misfolded SOD1
on motor axonal mitochondria which was not previously
appreciated (or possible to detect). Further investigation of this
mechanism is likely to yield important therapeutic targets.
Materials and Methods
Ethics statement
Animals were treated in strict accordance with approved
protocols from the Centre de Recherche du Centre Hospitalier
de l’Universite´ de Montre´al (CRCHUM) Institutional Committee
for the Protection of Animals (N08001CVsr) and the University of
California, San Diego Institutional Animal Care and Use
Committee (S00225). Both committees follow national standards
as outlined by the Canadian Council on Animal Care (CCAC) and
the American Association for Laboratory Animal Science
(AALAS), respectively. All possible efforts were made to minimize
any suffering.
Generation of transgenic mice
The pHb9-MitoEGFP was generated by introducing the
mitochondrial targeting sequence of Cytochrome c Oxidase
subunit VIII into pHb9-EGFP via standard cloning techniques.
Transgenic founders (from F1 C57Bl/6 parental mice) were
generated by pronuclear injection of a 10 kb NotI-PacI fragment
containing pHb9-MitoEGFP. Five founders were identified via
PCR, four of which were fertile, and lines were established and
backcrossed into a C57Bl/6 background for at least three
generations. Genotypes were determined by PCR using the
following primers: 59-CGTCAGGCTAATTGGACCGTG-39, 59-
CCGTAGGTGGCATCGCCCTC-39, and 59-CTTACGGA-
GACTGAGCGTGGC-39. Subline 34-116 Hb9-MitoEGFP mice
were mated to previously described SOD1G85R [14] and
SOD1G37R [13] mice. Resulting Hb9-MitoEGFP/SOD1 animals
(or Hb9-MitoEGFP littermates) were perfused at various times in
order to establish a time line for the disease in reference to
mitochondrial shape and distribution.
Immunoblotting, immunofluorescence and antibodies
Spinal cords were processed for immunoblot analysis as
previously described [14] using a polyclonal anti-EGFP antibody
and a monoclonal anti-a-tubulin (DM1A, Sigma) antibody.
Spinal cord, sciatic nerve, and L5 roots were dissected from
animals transcardially perfused with phosphate-buffered 4%
paraformaldehyde (FD NeuroTechnologies). Tissues were then
post-fixed for 2 hours, cryoprotected, and then embedded in OCT
(TissueTek) [14]. Sections (spinal cords: 30 mm; sciatic nerve and
L5 roots: 10 mm) were labeled with one or more antibodies,
including: SMI-32 (1:2000, Sternberger Monoclonals), cyto-
chrome c (1:200, BD Biosciences), MBP (1:200, Chemicon) or
mAb A5C3 (misfolded SOD1, 1:100; Gros-Louis et al., 2010).
Labeling was visualized via fluorescently conjugated anti-mouse or
rat antibodies (Cy5 or Texas Red; Jackson Immunochemicals). All
antibodies were diluted in blocking buffer (3% fetal calf serum,
0.2% Tween-20 in PBS. Sciatic nerves were additionally labeled
with Fluoromyelin Red (1:300, Molecular Probes). All sections
were mounted with ProLong Antifade reagent (Invitrogen) and
analyzed with a confocal microscope (Leica SP5; 63x oil, 1.7 NA;
digital zoom of 2–4.5x). A minimum of 2–5 animals per genotype
for each age (each with 2–5 images each) were collected for
analysis. For colocalization, Leica LAS AF software was used to
calculate the overlap coefficient between misfolded SOD1 (A5C3)
and individual mitochondria (MitoEGFP) in ventral roots.
Specifically, MitoEGFP+ mitochondria were selected using the
‘‘region of interest’’ tool in 5–10 axons of each genotype
(SOD1G37R: 10 axons with 34 mitochondria; SOD1G85R: 5 axons
with 26 mitochondria) and the overlap coefficient was recorded.
An overlap coefficient value of one represents the maximum
degree of colocalization, and zero indicates no colocalization. This
method has been applied previously [33].
Quantitation of mitochondrial parameters and
distribution
Detection of mitochondria: Image processing was performed using
custom software written in MATLAB (MathWorks, Natick, MA).
Confocal reconstructions were separated into monochromatic
green and red channels, for detection and analysis of mitochondria
(MitoEGFP) and axonal geometry (myelin), respectively. Blind
deconvolution (four iterations, with an initial estimate for the size
of the point spread function equal to four) was used to yield
separation of individual mitochondria. Otsu’s method was then
used to generate a thresholded binary image. A series of
morphometric operations was used to clear single pixels, break
residual connections between mitochondria, and smooth the
surface of each mitochondrion. These operations detected
,90% of mitochondria accurately. The remaining 10% reflected
mitochondria with more complex connecting linkages were
separated manually, resulting in an overall detection error of
,1% of mitochondria compared to manual selection.
Mitochondrial geometry, densities, and localization. Areas
of each mitochondrion were calculated based on the number of
pixels composing each separate object. Each mitochondrion was
then fit to an elliptical shape, and the major and minor axes
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(mitochondrial length and width) as well as the coordinates of the
ellipse (mitochondrial position) were determined. Aspect ratio was
determined as the ratio of mitochondrial length to width; round
mitochondria were represented by aspect ratios close to one.
Axonal geometry and coordinates for the center of SLIs were
identified from the red (myelin) channel. Axons were divided into
bins of 3.5 mm and mitochondrial density was calculated within
each bin based on the coordinates of each mitochondrial centroid.
Variability in the distribution of mitochondria along the length of
the axon was quantified by fitting the histogram of mitochondrial
density versus position along the axon with linear regression.
Mitochondrial densities proximal to SLIs were calculated,
respectively, based on the average mitochondrial density for a
7.0 mm region (two bins) proximal to each incisure. These were
compared to mitochondrial densities for all remaining bins not
associated with an incisure. Accumulation or clustering of
mitochondria at SLIs was reflected by a ratio of SLI to non-SLI
density greater than 1. Normal mitochondrial distribution along
the length of the axon resulted in a ratio less than or equal to 1,
based on the gradual tapering of axonal diameter at SLIs. Details
of the number of mitochondria analyzed are in Table 1.
Statistics. Significant differences in mean values for
parameters described above were tested using 2-way ANOVA
analysis for time and genotype. ANOVA calculations for somal
mitochondria area, length and aspect ratio were calculated as
,0.0001. Axonal mitochondria length and aspect ratio also
yielded ANOVA values ,0.0001. Where data was significant for
an interaction, we followed up with a post-hoc two-tailed t-test
assuming unequal variances to assess differences between specific
groups. t-test values are reported in text. Significant differences in
distributions for parameters described above were tested using the
Chi-square test with Yates’ correction for continuity.
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